HealthLeaders Media April 24, 2024
Spending on weight-loss drugs will continue to climb in 2024 and beyond as drug makers catch up with the huge global demand.
Eric Tichy, PharmD, MBA, division chair, supply chain management at Mayo Clinic, is lead author of a new study detailing how and where the U.S. spent $772 billion on drug in 2023, up 13.5% from 2022, and what’s in store for 2024.
In this HealthLeaders interview, Tichy explains how weight-loss drugs pushed double-digit increases in drug expenditures last year, even as drug price increases were relatively modest.
Tichy projects that spending on weight-loss drugs will continue to climb in 2024 and beyond as suppliers catch up with the huge global demand. That growth will continue as new...
Today's Sponsors
Today's Sponsor